Joseph DiMasi

Joseph DiMasi is a Research Associate Professor in the Department of Public Health and Community Medicine at Tufts University School of Medicine. He holds a PhD from Boston College and a BA from the University of Massachusetts, Boston.

His research focuses on pharmaceutical R&D economics, including drug development timelines, costs, regulatory strategies, and clinical trial optimization. He has contributed to studies on decentralized trials, digital endpoints, and the financial implications of regulatory changes globally, such as those in China. His work frequently examines industry benchmarks, risk management in drug development, and policy impacts on innovation.

DiMasi has been involved in multiple high-impact grants funded by organizations like the National Institutes of Health and industry partners such as Pfizer and GlaxoSmithKline. His professional activities include speaking engagements on topics like R&D productivity metrics, clinical trial efficiency, and the economics of biopharmaceutical innovation. While no specific awards are listed, his extensive publications and industry collaborations highlight his expertise in drug development economics.

He advises on strategic R&D decisions and has authored over 100 peer-reviewed articles, with a focus on translating research into actionable insights for policymakers and industry leaders. His affiliations include the Tufts Center for the Study of Drug Development, where he contributes to comprehensive analyses of global pharmaceutical trends.